Mixed reactions from pharma to Union Budget 2025
Appreciate extending full exemption and concessional tariffs to bulk drugs used for selected lifesaving drugs but hope for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Nikhil Chopra
Pharma sector gears up for Budget 2025-26; urges for strong regulatory framework and faster approval…
Industry leaders share their expectations from the upcoming Union budget 2025-26. Increased allocation for R&D and…
JB Pharma publishes its second ESG report for FY 2022-23
JB Pharma reported 19 per cent decrease in GHG intensity as compared to last year
JB Pharma: Betting big on India
Our biggest bet is India and the CDMO space, says Nikhil Chopra, CEO, JB Pharma, taking stock of the company's ongoing transition…
JB Chemicals closely watching for acquisition opportunities
Nikhil Chopra, CEO and Whole Time Director, JB Chemicals and Pharmaceuticals, tells Akanki Sharma about his focus on acquiring…
My role is to act like a catalyst
Nikhil Chopra recently took over as CEO and Whole-time Director of JB Chemicals & Pharmaceuticals. In a free-wheeling…
JB Chemicals & Pharmaceuticals appoints Nikhil Chopra as CEO
The Board of directors of JB Chemicals & Pharmaceuticals appointed Nikhil Chopra as Whole-time Director and Chief Executive…
Cipla launches Cipremi, likely to price it Rs 4,000 per vial
It is looking to supply over 80,000 vials within the first month
Cipla acquires four nutraceutical brands of Wanbury
The nutraceutical products will address various health needs for conditions arising due to nutritional deficiencies or…